Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes

NCT01465152 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: metformin
DRUG: repaglinide

Sponsor

Novo Nordisk A/S